References: |
1. Sinus floor augmentation with simultaneous placement of dental implants in the presence of platelet-rich plasma or recombinant human bone morphogenetic protein-7. Roldan JC, Jepsen S, Knuppel H, Clin Oral Implants Res 2004 Dec;15(6):716-23 2. Histological assessment of bioengineered new bone in repairing osteoperiosteal mandibular defects in sheep using recombinant human bone morphogenetic protein-7. Abu-Serriah MM, Odell E, Gillar A, Br J Oral Maxillofac Surg 2004 Oct;42(5):410-8 3. Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease. Li T, Surendran K, Mathew S, Curr Opin Nephrol Hypertens 2004 Jul;13(4):417-22 4. Bone morphogenetic protein-7 from serum of pregnant mice is available to the fetus through placental transfer during early stages of development. Borovecki F, Jelic M, Sampath KT, Nephron Exp Nephrol 2004;97(1):e26-32 5. Are recombinant human bone morphogenetic protein-7 and tobramycin compatible? An experiment in rats. Kawaguchi AT, Reddi AH, Yinger KE, J Orthop Trauma 2004 Apr;18(4):225-32 6. Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. Wang S, Hirschberg R, J Biol Chem 2004 May 28;279(22):23200-6 |